Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.

Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.

Pathology in most chronic inflammatory diseases is characterized by an imbalance in cytokine expression. Targeting cytokines with monoclonal antibodies has proven to be a highly effective treatment. However, monoclonal antibody therapy has disadvantages such as high production costs, generation of a...

書誌詳細
主要な著者:	Link, A, Bachmann, M
フォーマット:	Journal article
言語:	English
出版事項:	2010

類似資料

Immunodrugs: therapeutic VLP-based vaccines for chronic diseases.
著者:: Jennings, G, 等
出版事項: (2009)

Anticytokine Autoantibodies and Fungal Infections
著者:: Shanthi Kappagoda, 等
出版事項: (2023-07-01)

Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation
著者:: Vijaya Knight, 等
出版事項: (2016-01-01)

CLINICAL EXAMPLES OF ANTICYTOKINE TREATMENT OF CHILDREN WITH CROHN DISEASE
著者:: M.M. Venediktova, 等
出版事項: (2011-09-01)

CLINICAL EXAMPLES OF ANTICYTOKINE TREATMENT OF CHILDREN WITH CROHN DISEASE
著者:: M.M. Venediktova, 等
出版事項: (2011-01-01)

Profiling Serum Cytokines and Anticytokine Antibodies in Psoriasis Patients
著者:: Dan Hong, 等
出版事項: (2022-01-01)

Anticytokine therapy for periodontal diseases: Where are we now?
著者:: Waykole Yogesh, 等
出版事項: (2009-01-01)

Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
著者:: A. Yu. Baranovsky, 等
出版事項: (2012-06-01)

Can anticytokine therapy prevent unfavourable course of ulcerative colitis?
著者:: A. Yu. Baranovsky, 等
出版事項: (2013-12-01)

Anticytokine therapy with interleukin-17 in patients with moderate and severe psoriasis
著者:: Julia S. Kovaleva, 等
出版事項: (2024-03-01)

INTERLEUKIN-17A IS A NEW TARGET OF ANTICYTOKINE THERAPY FOR ANKYLOSING SPONDYLITIS
著者:: Sh. F. Erdes
出版事項: (2016-09-01)

Modulation of T cell function by combination of epitope specific and low dose anticytokine therapy controls autoimmune arthritis.
著者:: Sarah T A Roord, 等
出版事項: (2006-01-01)

Assessment of the State of Cell Membranes against the Background of Prolonged Use of Anticytokine Therapy in Patients with Ulcerative Colitis
著者:: E. Yu. Chashkova, 等
出版事項: (2019-11-01)

Fraxin in Combination with Dexamethasone Attenuates LPS-Induced Liver and Heart Injury and Their Anticytokine Activity in Mice
著者:: Nada Sahib Shaker, 等
出版事項: (2023-01-01)

PROMOTER POLYMORPHISM -857С>T OF TNFα GENE AND EFFICACY OF ANTICYTOKINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
著者:: A. N. Silkov, 等
出版事項: (2014-07-01)

Treatment of COVID-19-Releated Hyperinflammatory Response In Intensive Care Unit: Pulse Steroid, Anticytokines, IVIG, Plasmapheresis.
著者:: Alev Öztaş, 等
出版事項: (2022-03-01)

ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES
著者:: E. V. Voronina, 等
出版事項: (2018-12-01)

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance
著者:: DC Whitacre, 等
出版事項: (2020-02-01)

Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance
著者:: Noémi Anna Nagy, 等
出版事項: (2021-05-01)

Activation of the MEK-ERK Pathway Is Necessary but Not Sufficient for Breaking Central B Cell Tolerance
著者:: Sarah A. Greaves, 等
出版事項: (2018-04-01)

Alphavirus Replicon Particle Vaccine Breaks B Cell Tolerance and Rapidly Induces IgG to Murine Hematolymphoid Tumor Associated Antigens
著者:: Hsuan Su, 等
出版事項: (2022-05-01)

Corrigendum: Activation of the MEK-ERK Pathway Is Necessary but Not Sufficient for Breaking Central B Cell Tolerance
著者:: Sarah A. Greaves, 等
出版事項: (2018-09-01)

Complete Regression of Giant Aneurysms in an Infant with Delayed Diagnosis and Refractory Kawasaki Disease via Combination Anticytokine Therapy: Case Report and Review of Similar Cases
著者:: Maegan Williams, 等
出版事項: (2020-01-01)

Role of B Cells in Breaking and Maintaining Tolerance to Clotting Factor VIII in Congenital and Acquired Hemophilia A
著者:: Amanda M. Actor, 等
出版事項: (2014-04-01)

Therapeutic vaccination to block receptor-ligand interactions.
著者:: Spohn, G, 等
出版事項: (2003)

CD84 as a therapeutic target for breaking immune tolerance in triple-negative breast cancer
著者:: Stav Rabani, 等
出版事項: (2024-11-01)

Therapeutic vaccines for chronic diseases: successes and technical challenges.
著者:: Bachmann, M, 等
出版事項: (2011)

Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity
著者:: Jonathan A. Hensel, 等
出版事項: (2019-03-01)

Trace levels of innate immune response modulating impurities (IIRMIs) synergize to break tolerance to therapeutic proteins.
著者:: Daniela Verthelyi, 等
出版事項: (2010-12-01)

Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy
著者:: Cody D. Moorman, 等
出版事項: (2021-03-01)

Use of virus-like particles for therapeutic vaccination against addiction and other chronic diseases
著者:: Bachmann, M
出版事項: (2005)

B-cell tolerance.
著者:: Ferry, H, 等
出版事項: (2006)

T cell tolerance induced by therapeutic antibodies.
著者:: Cobbold, S
出版事項: (2005)

Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways
著者:: Arshi Khanam, 等
出版事項: (2023-04-01)

Is B cell tolerance essential for transplantation tolerance?
著者:: Wood, K
出版事項: (2005)

Mechanisms of B-cell tolerance.
著者:: Klaus, G, 等
出版事項: (1976)

Symmetry breaking [electronic resource]: /
著者:: 397572 Strocchi, F., 等
出版事項: (2007)

T cell tolerance in transplantation: possibilities for therapeutic intervention.
著者:: Cobbold, S
出版事項: (2002)

Live Typhoid Vaccine for IBD-Patients—Well Tolerated and with Possible Therapeutic Effect
著者:: Arnold Berstad, 等
出版事項: (2008-01-01)

Live Typhoid Vaccine for IBD-Patients–-Well Tolerated and with Possible Therapeutic Effect
著者:: Gunnar Nysæter Dr., 等
出版事項: (2008-01-01)